He was previously on numerous weight loss programs as well as medications with no long-term success.
He also has numerous [**Hospital 43094**] medical problems including type 2 diabetes, severe sleep apnea, hypertension, gastroesophageal reflux disease, and chronic back pain.
He was evaluated for Roux-en-Y gastric bypass procedure.
Uvulectomy for treatment of sleep apnea in [**2141**].
NPH Insulin 60 units q.a.m.
Glucophage 1,000 mg p.o.
Avandia 4 mg q. day.
Verapamil 180 mg p.o.
Zestril 5 mg p.o.
Lipitor 10 mg p.o.
Protonix 40 mg p.o.
Allopurinol 75 mg p.o.
Aspirin 325 mg p.o.
Zoloft 50 mg p.o.
HOSPITAL COURSE:  Mr. [**Known lastname 43093**] was admitted to the operating room on [**2143-3-22**] where he underwent open Roux-en-Y gastric bypass and cholecystectomy.
The patient tolerated the procedure well and was transferred postoperatively to the postanesthesia care unit.
The was given sublingual nitroglycerin, a beta blocker was started, and the patient was placed on telemetry with rule out procedure for myocardial infarction begun.
The patient's chest pain resolved significantly after three rounds of sublingual nitroglycerin tablets.
His chest pain resolved without further medication and was present by postoperative day number two with only a cough.
At this time on postoperative day number two the decision was made to discontinue the patient's nasogastric tube and begin a stage I diet.
His Foley catheter was removed and he was changed over to oral medications.
Morbid obesity status post Roux-en-Y gastric bypass and cholecystectomy.
Multivitamin, one tablet p.o.
Lopressor 37.5 mg p.o.
Zoloft 50 mg p.o.
Lipitor 10 mg p.o.
Allopurinol 75 mg p.o.
